Factors associated with treatment intensification in patients with axial spondyloarthritis and high disease activity in clinical practice.
Casper WebersRabab Nezam El-DinEsther BeckersMarin BeenHarald E VonkemanAstrid van TubergenPublished in: Rheumatology (Oxford, England) (2023)
In practice, treatment is intensified in a minority of axSpA patients with HDA. Physician-centered factors are associated with the decision to change treatment, independently of disease activity or patient perspective. Further research is needed to better understand these decisions.